Mengke Qu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 3
- Extracellular vesicles in disease 2
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Qing Lin (10 shared papers)Zhirong Zhang (8 shared papers)Ling Zhang (4 shared papers)Shanshan He (4 shared papers)Yao Fu (2 shared papers)Yu Fu (6 shared papers)Xun Sun (4 shared papers)Luyao Wang (2 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Advanced Functional Materials (2 papers)Nano Research (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Nanoscale (1 paper)
- Partner nations
- ChinaSwedenUnited Kingdom
In The Last Decade
Mengke Qu
10 papers receiving 784 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 266
- Pharmaceutical Science 66
- Biomaterials 140
- Molecular Biology 593
- Neurology 62
Countries citing papers authored by Mengke Qu
This map shows the geographic impact of Mengke Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengke Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengke Qu more than expected).
Fields of papers citing papers by Mengke Qu
This network shows the impact of papers produced by Mengke Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengke Qu. The network helps show where Mengke Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengke Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease Hit paper breakdown → | 2018 | 446 |
| 2 | 2018 | 99 | |
| 3 | 2019 | 78 | |
| 4 | 2018 | 56 | |
| 5 | 2018 | 32 | |
| 6 | 2019 | 26 | |
| 7 | 2018 | 19 | |
| 8 | 2019 | 18 | |
| 9 | 2015 | 15 | |
| 10 | 2018 | 3 |
About Mengke Qu
Mengke Qu is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Pharmaceutical Science and Organic Chemistry, having authored 10 papers that have together received 792 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Graphene and Nanomaterials Applications (2 papers), Extracellular vesicles in disease (2 papers), Pancreatic function and diabetes (1 paper), MicroRNA in disease regulation (1 paper), Nerve injury and regeneration (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Cancer Research (266 citations), Pharmaceutical Science (66 citations), Biomaterials (140 citations), Molecular Biology (593 citations) and Neurology (62 citations). Mengke Qu has collaborated with scholars based in China, Sweden and United Kingdom. Frequent co-authors include Qing Lin, Zhirong Zhang, Ling Zhang, Shanshan He, Yao Fu, Yu Fu, Xun Sun, Luyao Wang, Shengyong Yang and Luyi Huang. Their work appears in journals such as Journal of Controlled Release, Advanced Functional Materials, Nano Research, European Journal of Pharmaceutical Sciences and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.